Greg is a Managing Director of the Concorde Companies, and is a Principal in the portfolio management team for both public securities and private investments in addition to overseeing regulatory compliance as chief compliance officer. He is also a Managing Director of Omnimed Capital, a healthcare focused Venture Capital investment group.  Prior to joining Concorde, Greg spent a decade in banking for JP Morgan and Wells Fargo, as a troubled asset work-out specialist, and covered a variety of businesses including healthcare, gaming, distribution companies, import businesses, manufacturing, technology, services, and agriculture.

He currently serves on the Board of Pattern Bioscience, an in vitro diagnostics company based in Austin, Texas. He is also the Chairman of the Endowment Foundation Investment Committee for the Ronald McDonald House of Dallas. Greg is a member and the former Texas State Chair of the Society of International Business Fellows, a leadership organization consisting of 1400 senior business executive level, government officials, and NGO members in four regional networks in 45 countries and completed their North American Leadership Academy in 2015. Greg completed his undergraduate work at the University of Texas at Austin and his Master of Business Administration focusing on Finance and Strategy at Southern Methodist University, where he served as President of the Student Advisory Board. 

Greg is a longtime Dallasite and is married with two sons and a daughter. Outside of work he enjoys spending time with his family, golfing, bird hunting, and Texas football.